Durezol and Hot flushes aggravated - a phase IV clinical study of FDA data

Summary:

Hot flushes aggravated is reported as a side effect among people who take Durezol (difluprednate), especially for people who are female, 60+ old, also take Mobic, and have Cataplexy.

The phase IV clinical study analyzes which people have Hot flushes aggravated when taking Durezol. It is created by eHealthMe based on reports of 3,405 people who have side effects when taking Durezol from the FDA, and is updated regularly.

What is Durezol?

Durezol has active ingredients of difluprednate. It is often used in uveitis. eHealthMe is studying from 3,441 Durezol users. Check the latest studies of Durezol.

What is Hot flushes aggravated?

Hot flushes aggravated (sudden feelings of heat) is found to be associated with 1,522 drugs and 475 conditions by eHealthMe. Check the latest studies of Hot flushes aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

3,405 people reported to have side effects when taking Durezol.
Among them, 17 people (0.5%) have Hot flushes aggravated.

Could Durezol cause Hot flushes aggravated?

Among these 17 people:

What is the gender of people who have Hot flushes aggravated when taking Durezol? *

female: 75 %
male: 25 %

What is the age of people who have Hot flushes aggravated when taking Durezol? *

What are other drugs people take besides Durezol? *

What are other side effects people have besides Hot flushes aggravated? *

Weight Increased: 9 people, 52.94%
Osteoporosis (bones weak and more likely to break): 8 people, 47.06%
Irritable Bowel Syndrome: 8 people, 47.06%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 8 people, 47.06%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 47.06%
Autoimmune Hepatitis: 8 people, 47.06%
Drug Hypersensitivity: 3 people, 17.65%
Itching: 3 people, 17.65%
Urine Odor Abnormal: 2 people, 11.76%
Night Sweats (sweating in night): 2 people, 11.76%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 47.06%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 47.06%
Urge Incontinence (urinary incontinence): 1 person, 5.88%
Prostate Cancer Metastatic: 1 person, 5.88%
Prostate Cancer: 1 person, 5.88%
Motion Sickness (travel sickness): 1 person, 5.88%
Micturition Urgency (urgency to pass the urine): 1 person, 5.88%
Metastases To Kidney (cancer spreads to kidney): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Durezol and have Hot flushes aggravated?

- Check whether Hot flushes aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Durezol:

Durezol (3,441 reports)

Browse all side effects of Durezol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hot flushes aggravated:

Hot flushes aggravated (1,522 drugs)

Browse all the conditions that are associated with Hot flushes aggravated:

Hot flushes aggravated (475 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on difluprednate (the active ingredients of Durezol) and Durezol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.